{"name":"MDI Therapeutics, Inc.","slug":"mdi-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxOY0dBSE1QYlhDQm9YMnQ2YVY1Qk83dWxlMUt4Vm5wb1JJZXhoTWFUOWJWWDJWR21IRWo3cGVpQVdIczZEd0NNY0g4akg1LV9KbHdUR0dZbWxxVjlwTnlocWV3YlIxdWxEVGQ5bFV5dzZVbVJ5UjFCSXVmWWxrVTFoMWk3MGo3SjRDbmJVMTFERE85YVM0MExQeVBQVlV5d2JPd2dHWkN3R0ZyQzlvU2VxbEh2WnRhbzRCMDk1ZzJHZlJMR00wc0VvRTZWT1drVVhpOXN6ZUJlaFNNb0ZEcEdQU3BId05Ua3NSN1kxTDMwVUw0RmU5c2tDM0NZbWRrZw?oc=5","date":"2025-10-29","type":"regulatory","source":"GlobeNewswire","summary":"Amneal Receives U.S. FDA Tentative Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol - GlobeNewswire","headline":"Amneal Receives U.S. FDA Tentative Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxPWXczdUR1STFmNUJaWkp5cE1NQTVLT1I0S3d0S0xKZXE5ejNmaHRUTWlXOUI0YUhWcERhaF95UEdMc19JQ2xvTzFWR3lJc095LWl2OVB1WG45RzhHRnJqUmIyOUNZQWdZc3A2VGIxeDZGT3cxNU1DazZJYmlsYzBqUDFaeUhTLUlrcFJHei0tNDcxM2pCcFRPcXV5V21xYVRnYThEZGcxYlZ6djM3NERGWUpmVzZac1AxMmxERldrbjB4OXA5aTNMYms2SHVQckZBTVNV?oc=5","date":"2025-10-23","type":"trial","source":"European Pharmaceutical Review","summary":"Phase III data for next-gen green inhaler push GSK closer to Net Zero targets - European Pharmaceutical Review","headline":"Phase III data for next-gen green inhaler push GSK closer to Net Zero targets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxPdk04TWowRGhtWkpnUEJmR3phN2J0TWRYbjA5M1ZaUXdSaVpISllBMTFRY3BjQXVzcUNMYkZzY2I2Q2RpaVdiYmtVR1dJN3RyWi1kZjVvQWtPVTFIWjh3SmQtaTZJMjA4cjc2bXJ5OHkwNUNudExDd3Y0aDBQeEpHZzJ6dk9INnZ1bE5NX3l4WDVDN3Jra0FibVdkV1lxMUdLdE14UHVfN3JVTkZsQWpFWEZSWkNkRGY0LXR5WXlXZUN6YjdCS1ZUUkQ3MnRrQXpKQ2ExU3VMdzh4SnRuNkZXWDN5bVQyTmM?oc=5","date":"2025-09-08","type":"pipeline","source":"GlobeNewswire","summary":"DPP1 Inhibitor Market Set to Reach New Heights in the Coming Decade | DelveInsight - GlobeNewswire","headline":"DPP1 Inhibitor Market Set to Reach New Heights in the Coming Decade | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxQR2hMczZSNm9ka1BJdWgtbEQxSlh4MS1oNUt1Z0tvdEVWT0FMalk4Y25OQjJEb1hKUFRuUHRZblB1ZzdJSUMtZHhZMTBQTVVtNS1uSzdyUVh3SU4zOS1JMEZfcnFVTm5oY1c2WGRfaXdYSGZXRTgtdmRieWhtMWlOeFNMOFN3WFFyUGNQLUhEcXh4a0JtZVlKLTFoVUxtNjVubmRZVkEwcnh3MHVyM0d4Z3lBRER3Yy1tZGIzaFdkbGV1VE5MS0Z1NmhFNW8xSWNnUzdSekUwUjdfWkZMTUc3UkxOVWlhaktYeFVkVFlsemJqeDFUbU05c0hzLTRTODN1dzdQanpRSmpSazNOZHdWMzZB?oc=5","date":"2025-08-25","type":"pipeline","source":"GlobeNewswire","summary":"Non-cystic Fibrosis Bronchiectasis Market Ready to Shift Gears with the Entry of First DPP1 Blocker | DelveInsight - GlobeNewswire","headline":"Non-cystic Fibrosis Bronchiectasis Market Ready to Shift Gears with the Entry of First DPP1 Blocker | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQS2R2aVhWLW9SVDgwSWgwS0xMb18zMkJKN3NjMXRfOE1XeXptYzZYaEcxTVBON1dUcmk3TW1iWHdYTjdXQUt6RDVEVlMzVmZ5U0JMYm14Z0F2c3FYOXVSOFVVME05a3pHMkRjRDdpbjJWQWYyeC1Pal80RFdEUU5yNzRLNXBMU1FQSmJqVnh3U3drV0kxUFVoY1FSYXVaWGFyVUVJ?oc=5","date":"2025-06-18","type":"pipeline","source":"BioWorld News","summary":"Newly launched Draig targeting depression with $140M series A - BioWorld News","headline":"Newly launched Draig targeting depression with $140M series A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE13WGpxc1ZZVGQwNy1ERk1Dd1hGV0FLdlEyU0tZLXpWbU5fc3Y4U0daNHl0WGp5dzZzY3U1XzVfZkRwSTBra1RTRDFQU2ZxYnlKMUFjejRmMUV0UHNyWndOZzVEQU9jNWk0dnlPUmpoWE1PUnN3Qk9yT3k4eVA3QQ?oc=5","date":"2025-04-29","type":"pipeline","source":"Future Market Insights","summary":"Metered Dose Inhalers Market 2025 to 2035 - Future Market Insights","headline":"Metered Dose Inhalers Market 2025 to 2035","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxONE5fVDhLV0sxNkFmQWhwQ05Wd0lOOVhoNTRxMTdMakY5QTY5WnNyWnpMQnZkeEVpZG1nUmZJcXFMSkhJXzVpMnBFMGJyUW4zY1NobTZoOVBRLUN3WnlLZ3ZVNU1qVU0zeWl0cTVlWDUzaWdRNm9ybFhzSVlMQU1nUjBoNms2X21jdDNqRFVWUmNOaVR6UkxVSlotTkRzR1VOSHZrUlpJVGtKR2U4S3ZlWjJKQjVpbXkzVjJSNmxRWGVyMkl1MDk5Tk55UU9jVkU?oc=5","date":"2025-03-18","type":"deal","source":"PR Newswire","summary":"Cipla and Formosa sign multi-regional licensing deal for Clobetasol Suspension - PR Newswire","headline":"Cipla and Formosa sign multi-regional licensing deal for Clobetasol Suspension","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxNakdDUHRsU1Q4Z2FBclZNd0Fyb3NWSWVaOUZSQ1ZGZnE4WTNzcGljNzl5NW1iY1o0Zl9xUEw2eHVMSFM3cUpxUmsweC1mQ21MbXJMT2FBSU5Tcngxa3pIN3c1c24zVTJOVXBjX0QxcmRVZDZUNXFBeV9ra19zZUlEeFczZ0xTT252X3Rmd09RbkxqaFJub0ZRVkJoUDU1UGZKQVZZOGx2NS04ekRWS29IVjFPaE1BVXduWXpiRFN4eUlITHlFV1RRU2hUQ0pMdHNITGZpZTUyenNUc0JESThiLVc3OFlzaVBMTEN5bW8tX3dXeU1UVlE?oc=5","date":"2024-06-21","type":"deal","source":"Business Wire","summary":"Melodia Therapeutics and Alivexis Sign Exclusive License Agreement for Cathepsin C Inhibitor Program MOD-A - Business Wire","headline":"Melodia Therapeutics and Alivexis Sign Exclusive License Agreement for Cathepsin C Inhibitor Program MOD-A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxQUXRfRWQzTFppejN1MkthYjdqNDNmU2llOGVTbHBPVUhjZU5fVW5XN3FwWmFQLWcyZEstUkp3YXNrYjNBaEgybWdFRXlzT2JLSlJMclJaTVZBNGxQVjBVNHg5U2tjeVFhc0dKdkhBWjRQdFNsVDdfN3RGOUttT212NFEyYzY2ZHlxaUIxU3pWNENiOVViQ0pabHpaaEx2Q1JSX0tYRy05RHFCQ1Qyc1g0Zm1EcU44MVB3OUl4aThTc2JSTGJ0OEdhVnB2OFBVWlNTWlp0MzRrc3hSS25ETmdLUC1oMEJSel9xbGZ3RE9vYl82SFU?oc=5","date":"2023-11-27","type":"pipeline","source":"respiratory-therapy.com","summary":"Pearl Therapeutics’ PT001 Demonstrates Positive Results in Patients with COPD - respiratory-therapy.com","headline":"Pearl Therapeutics’ PT001 Demonstrates Positive Results in Patients with COPD - respiratory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNeVN5b0liN28wcXdTdzEyNjZ6NWpQelR1dURjeVJCQ2s0WjZkWGpwdUtmb3hKRFZ5OExsNGItaFVNRi1lcFpzMTFFZHJRN1dCX0o3R0w3bkFvdU90cWprOUpQS0FuU1EtTi0xWGxfUWlFaDI5a3c2WVplbHpsRkUtVk5XcmIyaU96SEJZYTNtbVo?oc=5","date":"2023-04-10","type":"regulatory","source":"Timmerman Report","summary":"In Support of FDA’s Authority to Regulate Medicines - Timmerman Report","headline":"In Support of FDA’s Authority to Regulate Medicines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNTnliMTZNM3l5Njh2TFEzc0tLOUdSck1IaWVkVjBzMUlfRzlXelVTQTJYOV92OGZGd1NQSlBtT2FDX0J4TjhuUHNGZzNDYkw3T3J3Qk5xWUdvMnBWT041cEpKUWQzb2tYN0FXd0ZzY2hSb2xsLVY3aldueDVyNmFSeGtBdV9JTFo2Y0s3UmZ1a1pLM2VNUTVtaEhtZ3I2RWJ3eUE?oc=5","date":"2022-08-30","type":"trial","source":"globaldata.com","summary":"Idiopathic Pulmonary Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - globaldata.com","headline":"Idiopathic Pulmonary Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Upda","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQTDlFd2oyNlBuZ0lpOVZNT2ZqQjBTM0FrSUU0Z0x6WFNlMTU0ZXlYcWg0M0o4ZDVCMVRqQjktZVRkR2x3Nlh6Um5WYTU3RnlUdFdVbm9tZDFOajFWNlNUcE9SNWlUYjFFZFJDRFlkNGctX0J6RE1ucXc3OUtsR2tCc0FR?oc=5","date":"2020-05-07","type":"pipeline","source":"BioSpace","summary":"BetterLife Pharma Enters into a Licensing Agreement - BioSpace","headline":"BetterLife Pharma Enters into a Licensing Agreement","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}